FDA Program 7356.002B Repackers and Relabelers
Title:
FDA Program 7356.002B Repackers and Relabelers
Origin/Publisher:
FDA
Content:
The repackaging and relabeling of drugs under CGMP controls has been a problem of long standing. According to this Program Drug repackaging and relabeling are manufacturing processes which must be conducted in accordance with applicable CGMP requirements.